W. Douglas Fairlie

20.4k citations
103 papers · 8.7k indexed · 3 hit papers · h-index 45
  • Rheumatology top 0.5%
    • GDF15 and Related Biomarkers 11
  • Immunology top 1%
    • Macrophage Migration Inhibitory Factor 11
    • Cell death mechanisms and regulation 37
    • RNA Interference and Gene Delivery 17
    • Ubiquitin and proteasome pathways 11
    • Chemical Synthesis and Analysis 11
    • RNA and protein synthesis mechanisms 9
  • Physiology top 1%
  • Oncology top 2%
    • Autophagy in Disease and Therapy 9

W. Douglas Fairlie

102 papers receiving 8.7k citations

Hit Papers

Bax Crystal Structures Reveal How BH3 ...4441997202620062016250500750

Peers

W. Douglas Fairlie
Comparison fields: 5 of 135
  • Rheumatology 1.8k
  • Immunology 2.4k
  • Molecular Biology 5.6k
  • Physiology 1.3k
  • Oncology 1.3k
Replace David R. Booth with:
David R. Booth Australia
Mark R. Philips United States
Keiryn L. Bennett Austria
M G Low United States
Andrew C. Chan United States
Georg W. Bornkamm Germany
Michael Su United States
James M. McDonnell United Kingdom
D J McKean United States
Raymond J. Paxton United States
W. Douglas Fairlie relative to David R. Booth Australia David R. Booth's profile →
Citations per field
00.5×3.2×
David R. Booth · 1×
Citations per year

Countries citing papers authored by W. Douglas Fairlie

Since Specialization
Citations

This map shows the geographic impact of W. Douglas Fairlie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Douglas Fairlie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Douglas Fairlie more than expected).

Fields of papers citing papers by W. Douglas Fairlie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Douglas Fairlie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Douglas Fairlie. The network helps show where W. Douglas Fairlie may publish in the future.

Co-authorship network

The 25 scholars most cited alongside W. Douglas Fairlie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. Douglas Fairlie Line = papers co-authored together W. Douglas Fairlie links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20245
3 20244
4 20233
5 202128
6 20202
7 2019142
8 201744
9 2012317
10 201121
11 2009149
12 200978
13 200935
14 2008156
15 200429
16 2002110
17 2001177
18 200140
19 2001121
20 2000109

About W. Douglas Fairlie

W. Douglas Fairlie is a scholar working on Immunology, Molecular Biology and Parasitology, having authored 103 papers that have together received 8.7k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (37 papers), RNA Interference and Gene Delivery (17 papers), GDF15 and Related Biomarkers (11 papers), Ubiquitin and proteasome pathways (11 papers), Chemical Synthesis and Analysis (11 papers), Macrophage Migration Inhibitory Factor (11 papers), RNA and protein synthesis mechanisms (9 papers) and Autophagy in Disease and Therapy (9 papers). The work is most often cited by research in Rheumatology (1.8k citations), Immunology (2.4k citations) and Molecular Biology (5.6k citations). W. Douglas Fairlie has collaborated with scholars based in Australia, United States and Italy. Frequent co-authors include Erinna F. Lee, David C.S. Huang, Samuel N. Breit, Peter E. Czabotar, Peter M. Colman, Asne R. Bauskin, Brian J. Smith, Philippe Bouillet, Andreas Strasser and Mark F. van Delft. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026